Clinical Report: Assessing Large Language Models in Cancers with MSI
Overview
This study evaluates the performance of large language models (LLMs) in the context of microsatellite instability (MSI) in cancer. Using the Microsatellite Instability Cancer Benchmark (MSIC-Bench), the research highlights significant gaps in specialized knowledge among LLMs and introduces retrieval-augmented generation (RAG) as a potential solution.
Background
Microsatellite instability (MSI) is a critical biomarker in cancer that influences diagnosis, prognosis, and treatment strategies. Despite its importance, the application of artificial intelligence, particularly large language models (LLMs), in MSI-related cancer care is underexplored. Understanding how LLMs can assist in this domain could enhance personalized therapeutic approaches for MSI-positive patients.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
The MSIC-Bench framework was developed to evaluate LLMs on both foundational and frontier knowledge in MSI-related cancer.
Three LLMs (GPT-4o, Gemini 2.5 Pro, Claude Opus 4) were assessed across four prompting strategies.
Standard LLMs exhibited a significant deficit in specialized knowledge, impacting their performance.
Retrieval-augmented generation (RAG) shifted the error mode from knowledge deficits to information retrieval failures.
RAG systems can introduce 'false refusals,' which may degrade utility despite improving safety.
Integrating broad clinical guidelines with specialized knowledge in RAG architectures can enhance system robustness.
Clinical Implications
The findings suggest that while LLMs have potential in cancer care, their current limitations in specialized knowledge must be addressed. Implementing RAG architectures may improve the accuracy and reliability of LLM responses in clinical settings, ultimately aiding in the management of MSI-positive cancers.
Conclusion
This study underscores the need for further development of LLMs tailored to the complexities of MSI in cancer. By addressing knowledge gaps and optimizing retrieval strategies, LLMs can become valuable tools in personalized cancer therapy.
